HIV-LAMP-vax

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHIV-LAMP-vax
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionGlycosaminoglycan modulatorsLysosome-associated membrane glycoproteins agonists
TargetsLysosome-associated membrane glycoproteinsGlycosaminoglycan
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImmunomic Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunomic Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A